Neptune Wellness Solutions Inc. (NASDAQ: NEPT) stock fell -17.79% on Monday to $4.62 against a previous-day closing price of $5.62. With 0.21 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.14 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $6.7100 whereas the lowest price it dropped to was $4.4800. The 52-week range on NEPT shows that it touched its highest point at $86.96 and its lowest point at $4.40 during that stretch. Beta for the stock currently stands at 1.97.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NEPT was down-trending over the past week, with a drop of -23.26%, but this was down by -16.18% over a month. Three-month performance dropped to -35.29% while six-month performance fell -77.50%. The stock lost -94.87% in the past year, while it has lost -63.34% so far this year. A look at the trailing 12-month EPS for NEPT yields -176.39 with Next year EPS estimates of -6.67. For the next quarter, that number is -8.97. This implies an EPS growth rate of 67.10% for this year and 79.10% for next year.
Float and Shares Shorts:
At present, 0.60 million NEPT shares are outstanding with a float of 0.57 million shares on hand for trading. On Aug 30, 2023, short shares totaled 15010.0, which was 2.49% higher than short shares on Jul 30, 2023. In addition to Mr. Michael Cammarata as the firm’s Pres, CEO & Director, Mr. John S. Wirt serves as its Chief Legal Officer, Exec. VP of Legal & Bus. Affairs and Gen. Counsel.
Other institutions hold — of NEPT, in contrast to — held by mutual funds. Shares owned by individuals account for –.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, NEPT reported revenue of $16.27M and operating income of -$13.66M. The EBITDA in the recently reported quarter was -$12.78M and diluted EPS was -$0.72.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NEPT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NEPT analysts setting a high price target of $877.67 and a low target of $877.67, the average target price over the next 12 months is $877.67. Based on these targets, NEPT could surge 18897.19% to reach the target high and rise by 18897.19% to reach the target low. Reaching the average price target will result in a growth of 18897.19% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded NEPT stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 2 while that of sell transactions has risen to 1 over the past year. The total number of shares bought during that period was 140,230 while 34,348 shares were sold.